Heme binding compounds and use thereof

Details Heme binding compounds and use thereof Heme binding compounds and use thereof

1994-12-12

1995-11-07

Raymond, Richard L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514427, 514565, 514632, 5483361, 5483355, 5483391, 548560, 548561, 548562, 548557, 562560, 562556, 564227, A61K 31415, A61K 3140, A61K 31195, A61K 31155

Patent

active

054648580

ABSTRACT:
Inhibitors of nitric oxide formation from arginine useful for treating hypotension, inflammation, stroke and to restore vascular contractile sensitivity to the effects of .alpha..sub.1 adrenergic agonists are physiologically active compounds including N.sup..delta. -substituted ornithine or N.sup..epsilon. -substituted lysine moieties or monoalkyl carbon-substituted N.sup..delta. -substituted ornithine or N.sup..epsilon. -substituted lysine moieties, having the formula ##STR1## wherein R is (CH.sub.2).sub.y CH.sub.3 or H, R' is CH.sub.2 or C(H)(CH.sub.2).sub.y CH.sub.3, and R" is CH.sub.2 or C(H)(CH.sub.2).sub.y CH.sub.3, with y ranging from 0 to 5, and x is 0 or 1 and wherein none or only one of R, R' and R" provides an alkyl substituent on ornithine or lysine moiety, and wherein Q is a heme binding moiety and/or a sulfur-containing binding moiety and Q' is --NH.sub.2 when there is a double bond between the omega carbon and Q and Q' is .dbd.NH when there is a single bond between the omega carbon and Q, and physiologically acceptable acid addition salts thereof.

REFERENCES:
patent: 3637837 (1972-01-01), Fujimoto et al.
patent: 3798269 (1974-03-01), Cutler et al.
patent: 4001267 (1977-01-01), Argoudelis
patent: 4053651 (1977-10-01), Ondetti et al.
patent: 4438204 (1984-03-01), Deeg et al.
patent: 4568640 (1986-02-01), Rubin
patent: 4698442 (1987-10-01), Nestor et al.
patent: 5010095 (1991-04-01), Sterk et al.
patent: 5028627 (1991-07-01), Kilbourn
patent: 5059624 (1991-10-01), Monache et al.
patent: 5059712 (1991-10-01), Griffith
patent: 5115110 (1992-05-01), Wu et al.
patent: 5133866 (1992-07-01), Kauvar
patent: 5158883 (1992-10-01), Griffith
patent: 5196195 (1993-03-01), Griffith
patent: 5216025 (1993-06-01), Gross et al.
patent: 5246971 (1993-09-01), Williamson et al.
patent: 5266594 (1993-11-01), Dawson et al.
patent: 5281627 (1994-01-01), Griffith
patent: 5286739 (1994-02-01), Kilbourn et al.
patent: 5296466 (1994-03-01), Kilbourn et al.
patent: 5380945 (1995-01-01), Murad et al.
Miller, M. J. S., et al, Agents Actions 39, Special Conference Issue C180-C182, 1993.
Corbett, J. A., et al, J. Clin. Invest. 90, 2384-2391, 1992.
Kroncke, K-D, et al, Biochem. Biophys. Res. Commun. 175, 752-758, Mar. 1991.
Corbett, J. A., et al, Proc. Natl. Acad. Sci. U.S.A., 90, 1731-1735, Mar. 1993.
Ialanti, A., et al, European Journal of Pharmacology, 211, 177-182 (1992).
Mulligan, M. S., et al, Proc. Natl. Acad. Sci. U.S.A., 88, 6338-6342, Jul. 1991.
Mulligan, M. S., et al, Br. J. Pharmacol., 107, 1159-1162.
Misko, T. P., et al, European J. Pharmacol. 223, 119-125 (1939).
Lukic, M. L., et al, Biochem. Biophys. Res. Commun. 153, 1251-1256, 1988.
Adnot, S., et al, Proc. Int. Meeting 1991, Chemical Abstracts 119(5): 46606f.
Hishikawa, K., et al, 1992, Chemical Abstracts 117(1): 5022c.
Ortiz de Montellano, P. R., et al, Cytochrome P-450, Structure, Mechanism and Biochemistry, 273-275, Plenum Press, N.Y., 1986.
Gray, G. A., et al, Br. J. Pharmacol., 103, 1218-1224 (May 1991).
Aisaka, K., et al, Biochem. Biophys Res. Commun. 163, No. 2, 710-717 Sep. 15, 1989).
Julou-Schaeffer, G., et al, Am. J. Physiol. 259, H1038-H1043, Oct. 1990.
Bodanszky, M., et al. The Practice of Peptide Synthesis, Springer-Verlang, New York, 1984, pp. 48, 49, 153, 154.
Feldman, P. L., tetrahedron Lett., 32, 875-878, 1991.
Rees, D. D., et al, Br. J. Pharmacol., 96, 418-424 (1989).

Affiliated with

Also associated with

Rating

Heme binding compounds and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heme binding compounds and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heme binding compounds and use thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-197578